A high PSA means your prostate is releasing more protein into your bloodstream than expected, but it does not automatically mean you have cancer. PSA (prostate-specific antigen) is a protein made by the prostate gland, and small amounts normally circulate in your blood. When levels rise above roughly 4.0 ng/mL, doctors flag the result for further evaluation. The majority of men with elevated PSA turn out to have a non-cancerous cause.
What Counts as “High” Depends on Your Age
There isn’t a single universal cutoff. PSA naturally rises as you get older because the prostate grows over time. Age-adjusted reference ranges give a more accurate picture of what’s typical:
- Ages 40 to 49: up to 2.5 ng/mL
- Ages 50 to 59: up to 3.5 ng/mL
- Ages 60 to 69: up to 4.5 ng/mL
- Ages 70 to 79: up to 6.5 ng/mL
A PSA of 3.8 ng/mL in a 45-year-old is more concerning than the same number in a 72-year-old. This is why context matters far more than the raw number on your lab report.
Non-Cancerous Causes of Elevated PSA
Several common, treatable conditions push PSA higher. Benign prostatic hyperplasia (BPH), the age-related enlargement of the prostate that affects most men over 50, is one of the most frequent reasons. A larger prostate simply produces more PSA. Prostatitis, an infection or inflammation of the prostate, can spike PSA dramatically. In one study of men with acute prostatitis, 71% had PSA levels above 4 ng/mL. Even urinary tract infections can temporarily raise PSA because the infection often spreads to the prostate and seminal vesicles.
Certain everyday activities also cause short-term bumps. Ejaculation can raise PSA temporarily, which is why doctors recommend avoiding sex or masturbation for 24 hours before a test. Vigorous exercise, especially cycling, can do the same. If you did any of these things shortly before your blood draw, the elevated reading may not reflect your true baseline.
How PSA Relates to Cancer Risk
Higher PSA does correlate with a greater chance of prostate cancer, but the relationship is a sliding scale, not an on/off switch. A landmark study that biopsied nearly 3,000 men found cancer rates at every PSA level, even very low ones. Among men with PSA at 0.5 ng/mL or below, 7% still had cancer on biopsy. Among those with PSA between 3.1 and 4.0 ng/mL (technically “normal” by the old 4.0 cutoff), 27% had cancer.
This is exactly why there’s no magic threshold. Treating PSA as simply normal or abnormal hides important information. A PSA of 3.5 that jumped from 1.2 a year ago tells a very different story than a PSA of 3.5 that has been stable for five years.
What Doctors Look at Beyond the Number
A single elevated PSA reading is just the starting point. Doctors use several additional tools to figure out whether the elevation is concerning.
PSA Velocity
This measures how quickly your PSA is climbing over time. A slow, gradual rise is expected with aging. An increase of more than 0.75 ng/mL per year, or more than 25% per year, is considered suspicious. Calculating velocity requires at least three separate PSA tests spread over 18 months or longer, which is one reason your doctor may want to recheck rather than act on a single result.
PSA Density
This compares your PSA level to the size of your prostate, measured by ultrasound or MRI. A larger prostate naturally produces more PSA, so dividing your PSA by your prostate volume gives a more meaningful ratio. A PSA density of 0.15 or higher raises suspicion for cancer.
Free PSA Percentage
PSA circulates in two forms: bound to other proteins, or “free.” Cancer tends to produce more of the bound form, so a lower percentage of free PSA suggests higher risk. For men with PSA between 4.0 and 10.0 ng/mL, a free PSA percentage of 25% or less is the threshold that typically prompts further testing. A higher free PSA percentage is more reassuring and often points toward BPH rather than cancer.
Medications That Alter Your PSA
If you take finasteride or dutasteride for hair loss or an enlarged prostate, your PSA readings will be artificially low. These medications reduce PSA by roughly 50% after about six months of use. Your doctor will typically double your measured PSA to estimate your true level. Importantly, any confirmed rise in PSA while you’re on one of these medications is a red flag, even if the number still looks “normal” on paper, because the drug should be holding it down.
What Happens After a High PSA
The first step is almost always a repeat test. The American Urological Association recommends confirming that PSA is still elevated before moving to imaging, biomarkers, or biopsy. A one-time spike caused by infection, ejaculation, or exercise may resolve on its own.
If your PSA remains elevated or continues to climb, your doctor has several options. A digital rectal exam checks for lumps or hardness in the prostate by feel. Newer blood and urine tests (sometimes called biomarkers) can further estimate your risk of aggressive cancer and help you decide whether a biopsy is worthwhile. These include tests like the Prostate Health Index, the 4Kscore, and IsoPSA, each of which measures different characteristics of PSA or related proteins to refine your risk estimate beyond the standard PSA number.
MRI has become a common next step before biopsy. It can identify suspicious areas within the prostate, allowing doctors to target those spots during a biopsy rather than sampling randomly. If the MRI looks clean and biomarker tests are reassuring, you and your doctor may decide to monitor with repeat testing rather than proceed to biopsy right away.
When a biopsy is needed, a needle is inserted either through the perineum (the skin between the scrotum and rectum) or through the rectal wall to collect small tissue samples. A pathologist examines the tissue under a microscope to determine whether cancer cells are present and, if so, how aggressive they appear. The transperineal approach has become increasingly preferred because it carries a lower infection risk.
Why One Number Doesn’t Tell the Whole Story
PSA is a useful screening tool, but it’s imprecise. It detects prostate activity, not prostate cancer specifically. Roughly 75% of men who get a biopsy because of elevated PSA turn out not to have cancer. On the flip side, some cancers exist at PSA levels well below 4.0 ng/mL. The value of PSA testing lies in tracking it over time, combining it with other tests, and interpreting it in the context of your age, prostate size, family history, and symptoms. A high PSA is a reason to investigate further, not a reason to panic.